Metabolic Fate of Phenprocoumon in Humans
- 1 July 1985
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 74 (10) , 1037-1040
- https://doi.org/10.1002/jps.2600741003
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Phenylbutazone and Sulfinpyrazone Interaction With Oral Anticoagulant PhenprocoumonArchives of internal medicine (1960), 1982
- Lack of effect of cimetidine on action of phenprocoumonEuropean Journal of Clinical Pharmacology, 1982
- Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomesBiochemical Pharmacology, 1981
- Analysis of linear approaches to quantitative stable isotope methodology in mass spectrometryJournal of Mass Spectrometry, 1981
- The synthesis of C‐2 isotopically labeled optically pure warfarin and phenprocoumonJournal of Labelled Compounds and Radiopharmaceuticals, 1980
- The enantiomers of phenprocoumon: Pharmacodynamic and pharmacokinetic studiesClinical Pharmacology & Therapeutics, 1976
- The plasma elimination of the enantiomers of phenprocoumon in manJournal of Pharmacy and Pharmacology, 1976
- Synthesis and thin-layer chromatographic, ultraviolet, and mass spectral properties of the anticoagulant phenprocoumon and its monohydroxylated derivativesJournal of Medicinal Chemistry, 1975
- The assay of warfarin in plasma or stoolBiochemical Medicine, 1970
- PHENPROCOUMON, DIPHENADIONE, WARFARIN AND BISHYDROXYCOUMARINThe Lancet Healthy Longevity, 1964